Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00381121 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

University of Michigan "Nephrology Research BioBank"

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Aug 2026 to Aug 2030v17
  2. Site contact updatedv16
  3. Re-verified, no change to tracked fieldsv15
  4. Collaborators expanded, about 8 wordsv14 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  5. 4 versions Re-verified since Oct 23, 2018, no change to tracked fieldsv10-v13
Show 8 earlier versionsHide 8 earlier versions
  1. Primary and study completion dates: Aug 2056 to Aug 2026 Eligibility criteria revisedv9 Show all 2 changesShow less
    • Eligibility criteria revised

    See this version in full on ClinicalTrials.gov ↗

  2. Re-verified, no change to tracked fieldsv8
  3. Interventions: Kidney and/or Pancreas biopsy (Procedure) to not stated Eligibility criteria expanded, about 11 words · Study title expanded, about 3 wordsv7 Show all 3 changesShow less
    • Eligibility criteria expanded, about 11 words
    • Study title expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  4. Primary completion date: Aug 2056v6
  5. Re-verified, no change to tracked fieldsv5
  6. Study arms: 0 to 1v4
  7. Trial status: Not Yet Recruiting to Recruiting Site details revisedv3 Show all 2 changesShow less
    • Site details revised
  8. Study description shortened, about 9 wordsv2 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.
Trial Details
NCT Number NCT00381121
Lead Sponsor University of Michigan
Collaborators: amfAR, The Foundation for AIDS Research, Regeneron Pharmaceuticals
Conditions Chronic Kidney Disease
Enrollment 420 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov